HRT Financial’s Allergan plc AGN Stock Holding History

HRT Financial’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-8,100	Closed	-$1.36M	–	1691
2019 Q2	$1.36M	Buy	+8,100	New	+$1.12M	0.09%	226
2018 Q4	–	Sell	-2,600	Closed	-$495K	–	807
2018 Q3	$495K	Buy	+2,600	New	+$478K	0.08%	175

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

HRT Financial's AGN Position: Q3 2019 in Review

HRT Financial sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 23,487 shares — an estimated $3.93M sold.

HRT Financial first reported a position in AGN in Q2 2018 and held it in 5 quarters. The position peaked at $3.93M in Q2 2019. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

HRT Financial reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
HRT Financial sold 23,487 Allergan plc shares in Q3 2019, an estimated $3.93M.
HRT Financial first reported a position in Allergan plc in Q2 2018 and held it in 5 quarters.
HRT Financial's Allergan plc position peaked at $3.93M in Q2 2019.
921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on HRT Financial's 13F filing for Q3 2019, filed 14 Nov 2019.